ORICOric Pharmaceuticals, Inc.
Earnings
When Oric Pharmaceuticals, Inc. reports, what it reported each quarter, and how the stock took the results.
30 quarters. Mar 31, 2019 to Jun 30, 2026. mixed units.
Next results · Q3 2026Report filed
10-Q filed Nov 16, 2026
The 10-Q was filed Nov 16, 2026. Its figures are not on the desk yet.
- Quarter
- Q3 2026 · Ended Sep 30, 2026
Latest results
- Revenue
- —
- —
- Net income
- -$41.49M
- N/M
- EPS
- -$0.38
- N/M
- Revenue
- —
- —
- Net income
- -$35.77M
- N/M
- EPS
- -$0.34
- N/M
- Revenue
- —
- —
- Net income
- -$30.51M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$32.59M
- N/M
- EPS
- -$0.33
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q2 2026 | Jun 30, 2026 | Aug 3, 2026 · after-hours | Aug 3, 2026 | 34 d | 10-Q | — | — | -$0.38 | +27.6% | |
| Q1 2026 | Mar 31, 2026 | May 4, 2026 · after-hours | May 4, 2026 | 34 d | 10-Q | — | — | -$0.34 | 0.3% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Feb 23, 2026 · after-hours | Feb 23, 2026 | 54 d | 10-K | — | — | — | +14.5% | |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 · after-hours | Nov 13, 2025 | 44 d | 10-Q | — | — | -$0.33 | +0.4% | |
| Q2 2025 | Jun 30, 2025 | Aug 12, 2025 · after-hours | Aug 12, 2025 | 43 d | 10-Q | — | — | -$0.47 | +2.9% | |
| Q1 2025 | Mar 31, 2025 | May 5, 2025 · after-hours | May 5, 2025 | 35 d | 10-Q | — | — | -$0.42 | 11.6% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Feb 18, 2025 · after-hours | Feb 18, 2025 | 49 d | 10-K | — | — | — | +1.3% | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · after-hours | Nov 12, 2024 | 43 d | 10-Q | — | — | -$0.49 | +0.2% | |
| Q2 2024 | Jun 30, 2024 | Aug 12, 2024 · after-hours | Aug 12, 2024 | 43 d | 10-Q | — | — | -$0.45 | +11.8% | |
| Q1 2024 | Mar 31, 2024 | May 6, 2024 · after-hours | May 6, 2024 | 36 d | 10-Q | — | — | -$0.37 | 7.4% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 11, 2024 · after-hours | Mar 11, 2024 | 71 d | 10-K | — | — | — | 5.0% | |
| Q3 2023 | Sep 30, 2023 | Nov 6, 2023 · after-hours | Nov 6, 2023 | 37 d | 10-Q | — | — | -$0.44 | 1.4% | |
| Q2 2023 | Jun 30, 2023 | Aug 10, 2023 · after-hours | Aug 10, 2023 | 41 d | 10-Q | — | — | -$0.50 | +11.0% | |
| Q1 2023 | Mar 31, 2023 | May 8, 2023 · after-hours | May 8, 2023 | 38 d | 10-Q | — | — | -$0.53 | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 16, 2023 · after-hours | Mar 16, 2023 | 75 d | 10-K | — | — | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 7, 2022 · after-hours | Nov 7, 2022 | 38 d | 10-Q | — | — | -$0.63 | — | |
| Q2 2022 | Jun 30, 2022 | Aug 11, 2022 · after-hours | Aug 11, 2022 | 42 d | 10-Q | — | — | -$0.51 | — | |
| Q1 2022 | Mar 31, 2022 | May 9, 2022 · after-hours | May 9, 2022 | 39 d | 10-Q | — | — | -$0.59 | +1.1% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 21, 2022 · after-hours | Mar 21, 2022 | 80 d | 10-K | — | — | — | 32.0% | |
| Q3 2021 | Sep 30, 2021 | Nov 8, 2021 · after-hours | Nov 8, 2021 | 39 d | 10-Q | — | — | -$0.47 | — | |
| Q2 2021 | Jun 30, 2021 | Aug 10, 2021 · after-hours | Aug 10, 2021 | 41 d | 10-Q | — | — | -$0.57 | — | |
| Q1 2021 | Mar 31, 2021 | May 6, 2021 · after-hours | May 6, 2021 | 36 d | 10-Q | — | — | -$0.45 | 0.0% | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | Mar 23, 2021 · after-hours | Mar 23, 2021 | 82 d | 10-K | — | — | — | — | |
| Q3 2020 | Sep 30, 2020 | Nov 5, 2020 · after-hours | Nov 5, 2020 | 36 d | 10-Q | — | — | -$0.84 | +3.8% | |
| Q2 2020 | Jun 30, 2020 | Aug 5, 2020 · after-hours | Aug 5, 2020 | 36 d | 10-Q | — | — | -$0.51 | +13.9% | |
| Q1 2020 | Mar 31, 2020 | May 20, 2020 · after-hours | May 20, 2020 | 50 d | 10-Q | — | — | -$4.46 | 11.3% | |
| FY 2019 | ||||||||||
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | — | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | — | — | -$3.36 | — | |
| Q2 2019 | Jun 30, 2019 | — | — | — | — | — | — | -$3.19 | — | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | — | — | -$3.32 | — | |
Earlier years, FY 2019 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Oric Pharmaceuticals, Inc. · CIK 1796280 · Engraved from SEC EDGAR